Ovation Science Inc. OVATF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 41.50K | 47.60K | 48.50K | 45.50K | 46.30K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 41.50K | 47.60K | 48.50K | 45.50K | 46.30K |
| Cost of Revenue | 19.90K | 19.90K | 20.20K | 8.50K | 4.60K |
| Gross Profit | 21.60K | 27.70K | 28.30K | 37.00K | 41.70K |
| SG&A Expenses | 478.00K | 452.50K | 456.90K | 354.80K | 346.50K |
| Depreciation & Amortization | -- | -- | -- | 0.00 | 400.00 |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 498.00K | 472.50K | 477.20K | 364.30K | 352.70K |
| Operating Income | -456.50K | -424.90K | -428.70K | -318.70K | -306.40K |
| Income Before Tax | -473.80K | -444.10K | -451.10K | -297.40K | -330.60K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.47 | -0.44 | -0.45 | -0.30 | -0.33 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -473.80K | -444.10K | -451.10K | -297.40K | -330.60K |
| EBIT | -456.50K | -424.90K | -428.70K | -318.70K | -306.40K |
| EBITDA | -263.80K | -352.60K | -427.10K | -317.10K | -304.80K |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 148.81M | 145.35M | 141.89M | 140.46M | 140.46M |
| Average Diluted Shares Outstanding | 148.81M | 145.35M | 141.89M | 140.46M | 140.46M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |